Dr. Jay Bhattacharya, a Stanford health researcher, is in line to lead the National Institutes of Health. Early in the pandemic he argued against lockdowns and focusing on people at highest risk.
To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.
The National Institutes of Health has been reluctant to use its leverage as a biomedical research funder to influence drug pricing. Sen. Bernie Sanders is pressing NIH's new director to take action.
The horseshoe crab bleeding industry is in transition. One biomedical company agreed to more oversight, and a regulatory group is paving the way for drug companies to use animal-free alternatives.
Horseshoe crab blood is used to test vaccines around the world. But while Europe has approved a synthetic alternative, biomedical labs are bleeding more crabs from the Atlantic coast.
Tiny, robotic fish powered by human heart cells suggest that scientists are getting closer to their goal of building replacement hearts from living tissue.
The National Cancer Act became law 50 years ago. Cancer went from shameful taboo to one of the best-funded areas of medicine. Much of the credit for this transformation goes to one woman, Mary Lasker.
The National Cancer Act became law 50 years ago. Cancer went from shameful taboo to one of the best-funded areas of medicine. Much of the credit for this transformation goes to one woman, Mary Lasker.
It’s been seven months since Hurricane Maria devastated Puerto Rico. Blackouts continue. Utility crews on the island are still in emergency restoration...
